COSM has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
COSM has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Cosmos Health has the Financial Strength Rank of 5.
GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors:
1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.Cosmos Health did not have earnings to cover the interest expense. Cosmos Health's debt to revenue ratio for the quarter that ended in Sep. 2023 was 0.21. As of today, Cosmos Health's Altman Z-Score is -0.65.
For the Medical Distribution subindustry, Cosmos Health's Financial Strength, along with its competitors' market caps and Financial Strength data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Distribution industry and Healthcare sector, Cosmos Health's Financial Strength distribution charts can be found below:
* The bar in red indicates where Cosmos Health's Financial Strength falls into.
GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.
Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
Cosmos Health's Interest Expense for the months ended in Sep. 2023 was $-0.15 Mil. Its Operating Income for the months ended in Sep. 2023 was $-3.02 Mil. And its Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was $4.05 Mil.
Cosmos Health's Interest Coverage for the quarter that ended in Sep. 2023 is
Cosmos Health did not have earnings to cover the interest expense. |
The higher the ratio, the stronger the company's financial strength is.
2. Debt to revenue ratio. The lower, the better.
Cosmos Health's Debt to Revenue Ratio for the quarter that ended in Sep. 2023 is
Debt to Revenue Ratio | = | Total Debt (Q: Sep. 2023 ) | / | Revenue | ||
= | (Short-Term Debt & Capital Lease Obligation | + | Long-Term Debt & Capital Lease Obligation) | / | Revenue | |
= | (6.736 | + | 4.051) | / | 51.296 | |
= | 0.21 |
3. Altman Z-Score.
Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
The zones of discrimination were as such:
When Z-Score is less than 1.81, it is in Distress Zones.
When Z-Score is greater than 2.99, it is in Safe Zones.
When Z-Score is between 1.81 and 2.99, it is in Grey Zones.
Cosmos Health has a Z-score of -0.65, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.
Warning Sign:
Altman Z-score of -0.65 is in distress zone. This implies bankruptcy possibility in the next two years.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cosmos Health (NAS:COSM) Financial Strength Explanation
The maximum rank is 10. Companies with rank 7 or higher will be unlikely to fall into distressed situations. Companies with rank of 3 or less are likely in financial distress.
Cosmos Health has the Financial Strength Rank of 5.
Thank you for viewing the detailed overview of Cosmos Health's Financial Strength provided by GuruFocus.com. Please click on the following links to see related term pages.
Grigorios Siokas | 10 percent owner | 5 AG. GEORGIOU STR., PILEA, THESSALONIKI J3 TK57001 |
Suhel Bhutawala | director | 141 WEST JACKSON BOULEVARD, SUITE 4236, CHICAGO IL 60604 |
Nikolaos Bardakis | officer: Chief Operating Officer | 141 WEST JACKSON BOULEVARD, SUITE 4236, CHICAGO IL 60604 |
Manfred Ziegler | director | 141 WEST JACKSON BOULEVARD, SUITE 4236, CHICAGO IL 60604 |
Anastasios Aslidis | director | 11 CANTERBURY LANE, WATCHUNG NJ 07069 |
Pavlos Ignatiades | officer: Chief Operating Officer | KALAPATHAKI 5, PANORAMA, THESSALONIKI J3 55236 |
Georgios Terzis | officer: Chief Financial Officer | 2 MELITOS STR., NEA SMIRNI, ATTICA J3 17121 |
Peter Goldstein | director | 151 NORTH NOB HILL ROAD SUITE 321, FORT LAUDERDALE FL 33324 |
John James Hoidas | director | 9301 S. HARLEM AVENUE, OAK LAWN, CHICAGO IL 60453 |
Dimitrios Goulielmos | director, 10 percent owner, officer: CEO | 141 WEST JACKSON BLVD, SUITE 4236, CHICAGO IL 60604 |
Panagiotis Tolis | director, officer: Secretary | PERICLEOUS 50 STREET, ATHENS J3 15232 |
Panagiotis Drakopoulos | director, 10 percent owner, officer: CEO | 200 SOUTH WACKER DRIVE, SUITE 300, CHICAGO IL 60606 |
Vasileios Mavrogiannis | director, 10 percent owner, officer: CFO | TERTSETI 23 STREET, KESARIANI J3 16122 |
From GuruFocus
By ACCESSWIRE • 09-13-2023
By ACCESSWIRE • 12-08-2023
By ACCESSWIRE • 07-20-2023
By ACCESSWIRE ACCESSWIRE • 06-16-2023
By ACCESSWIRE • 06-29-2023
By ACCESSWIRE ACCESSWIRE • 05-31-2023
By ACCESSWIRE ACCESSWIRE • 05-25-2023
By GuruFocus Research • 10-12-2023
By ACCESSWIRE • 08-08-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.